UROBIOME THERAPEUTICS Trademark

Trademark Overview

On Friday, February 15, 2019, a trademark application was filed for UROBIOME THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the UROBIOME THERAPEUTICS trademark a serial number of 88303231. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 2, 2020. This trademark is owned by Urobiome Therapeutics, LLC.. The UROBIOME THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
urobiome therapeutics

General Information

Serial Number88303231
Word MarkUROBIOME THERAPEUTICS
Filing DateFriday, February 15, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 2, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical products development; Pharmaceutical research and development; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 8, 2019
Primary Code042
First Use Anywhere DateFriday, May 31, 2019
First Use In Commerce DateFriday, May 31, 2019

Trademark Owner History

Party NameUrobiome Therapeutics, LLC.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19801

Trademark Events

Event DateEvent Description
Monday, November 2, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, November 2, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 21, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 21, 2020FINAL REFUSAL E-MAILED
Tuesday, April 21, 2020FINAL REFUSAL WRITTEN
Tuesday, March 31, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 31, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 31, 2020ASSIGNED TO LIE
Monday, March 23, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 25, 2019NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, October 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 24, 2019NON-FINAL ACTION E-MAILED
Thursday, October 24, 2019NON-FINAL ACTION WRITTEN
Thursday, October 24, 2019USE AMENDMENT ACCEPTED
Wednesday, October 23, 2019AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, October 23, 2019USE AMENDMENT FILED
Tuesday, October 22, 2019TEAS AMENDMENT OF USE RECEIVED
Wednesday, October 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 23, 2019NON-FINAL ACTION E-MAILED
Wednesday, October 23, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 22, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 17, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 17, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 3, 2019NON-FINAL ACTION E-MAILED
Friday, May 3, 2019NON-FINAL ACTION WRITTEN
Monday, April 29, 2019ASSIGNED TO EXAMINER
Friday, March 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 19, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics urobiome development pharmaceutical research related cancer diseases treatment medicines products preparations